KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $260.68 $288.54 Friday, 26th Apr 2024 AMGN stock ended at $269.98. This is 0.223% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.24% from a day low at $265.72 to a day high of $271.68.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Sep 21, 2023 $272.07 $272.48 $267.70 $269.41 2 353 062
Sep 20, 2023 $265.00 $273.08 $263.97 $271.46 3 525 752
Sep 19, 2023 $263.14 $265.77 $262.47 $264.31 1 448 771
Sep 18, 2023 $263.38 $265.22 $261.96 $263.15 1 477 623
Sep 15, 2023 $263.76 $263.93 $259.82 $260.72 5 250 309
Sep 14, 2023 $258.90 $263.13 $258.65 $262.30 2 910 788
Sep 13, 2023 $259.34 $260.15 $257.02 $257.23 2 090 939
Sep 12, 2023 $262.68 $263.02 $257.86 $260.31 1 428 826
Sep 11, 2023 $258.21 $262.81 $257.41 $261.72 1 974 913
Sep 08, 2023 $255.75 $260.34 $255.08 $259.43 2 170 458
Sep 07, 2023 $250.54 $254.70 $250.54 $254.39 2 092 817
Sep 06, 2023 $254.44 $254.44 $248.38 $249.01 1 933 948
Sep 05, 2023 $256.71 $257.37 $253.92 $254.01 1 763 515
Sep 01, 2023 $258.68 $259.03 $256.10 $256.71 1 300 923
Aug 31, 2023 $258.22 $259.00 $256.29 $256.34 1 717 293
Aug 30, 2023 $260.00 $260.87 $256.95 $257.88 1 639 166
Aug 29, 2023 $257.36 $259.85 $256.82 $259.64 2 174 013
Aug 28, 2023 $256.96 $258.12 $255.14 $256.55 1 550 805
Aug 25, 2023 $257.11 $257.74 $254.81 $256.38 1 568 292
Aug 24, 2023 $256.73 $260.19 $256.18 $256.62 1 759 412
Aug 23, 2023 $259.50 $259.85 $255.98 $257.36 1 822 827
Aug 22, 2023 $260.24 $260.35 $257.35 $257.62 1 633 381
Aug 21, 2023 $261.58 $262.42 $259.01 $260.70 2 063 822
Aug 18, 2023 $262.61 $262.99 $261.07 $261.82 2 553 885
Aug 17, 2023 $263.87 $266.58 $263.27 $263.85 2 118 396
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT